Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 10, 2016Cancer ResearchOpen Access

IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSridevi ChallaUniversity of ChicagoJGJian-Ping GuoXDXiaowen DingStanford University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Challa et al. (2016) studied this question.

synapsesocial.com/papers/6ab205d46bd51e819fd77369https://doi.org/10.1158/0008-5472.can-16-0069
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib2004 · 4,369 citations
  2. 2Abstract 3228: Dichloroacetate reverses the Warburg effect, inhibiting growth and sensitizing breast cancer cells towards apoptosis2012 · 48 citations
  3. 3Inhibition of KRAS -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit2014 · 195 citations